[ET Net News Agency, 27 March 2026] EVEREST MED (01952) rose 10.7% to HK$38.4.
It hits an intra-day high of HK$38.48, breaking above the 50-D SMA of HK$37.772, and an
intra-day low of HK$34.26. The total shares traded was 3.79 million, with a value of
HK$140.84m. The active buy/sell ratio is 66:34, with net buying turnover of HK$41.75m.
GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive buying turnover of HK$8.47m,
with volume weighted average price of HK$37.367. CHINA INV INFO accounts for greatest net
responsive selling turnover of HK$15.39m, with volume weighted average price of HK$37.301.

Basic Information
=================

----------------------------------
Nominal 38.400 % Chg +10.73%
High 38.480 Low 34.260
Shares Tr 3.79m Turnover 140.84m
10-D SMA 35.564 %H.V 65.738
20-D SMA 35.738 VWAP 37.119
50-D SMA 37.772 RSI14 55.249
----------------------------------
Status: Breaking above the 50-D SMA, active buy/sell ratio is 66:34, with net buying
turnover of HK$41.75m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
EVEREST MED (01952) 38.40 +10.73
INNOVENT BIO (01801) 84.80 +6.80
XTALPI (02228) 9.42 +1.62
WUXI BIO (02269) 32.46 +2.92
WUXI APPTEC (02359) 114.80 +1.32
CSTONE PHARMA-B (02616) 8.08 +17.10
BEONE MEDICINES (06160) 172.40 +5.06
DUALITYBIO-B (09606) 269.40 +5.23
AKESO (09926) 122.70 -0.81
REMEGEN (09995) 90.85 +2.54
-----------------------------------------------
(ed)